Multiple omics study identifies an interspecies conserved driver for nonalcoholic steatohepatitis

Xiao-Jing Zhang1,2,3, Zhi-Gang She1,2, Junyong Wang1,2

  • 1Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China.

Summary

Lipotoxicity accelerates nonalcoholic steatohepatitis (NASH). Researchers identified arachidonate 12-lipoxygenase (ALOX12) as a key driver, exacerbating NASH by targeting acetyl-CoA carboxylase 1 (ACC1) for degradation.